Busan
South Korea
2
2024-07-11
2
2025-09-30
These are the the leading inventors for applications assigned to EYEBIO KOREA:
EYEBIO KOREA based in Busan, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof
#2 | 2019-01-03 ✅ Patent 10,913,788 granted on 2021-02-09Pharmaceutical composition for preventing or treating dry eyes
Also check out EYEBIO KOREA's (Busan, South Korea) applicant profile with 3 patent applications submitted.
584864 ⎘